May, 2021

article thumbnail

Biden Backs Suspending Patents on Covid Vaccines

NY Times

The Biden administration, siding with some world leaders over the U.S. pharmaceutical industry, came out in favor of waiving intellectual property protections for coronavirus vaccines.

Vaccines 140
article thumbnail

Study finds Germany trails Spain and the US in digital health

pharmaphorum

Germany is lagging behind other countries in the adoption of digital health, including Spain and the US, according to a new survey carried out on behalf of drugmaker Fresenius. . The three-country poll found that Spain is way out in front, with over half of people asked responding that digital is already playing a major role in the networking of healthcare facilities, diagnosing illnesses and telemedicine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CVS Health broadens commitment to improving clinical trial infrastructure

Outsourcing Pharma

The owner of the pharmacy giant has announced plans to partner with various stakeholders in an effort to effect improvements across the trial ecosystem.

140
140
article thumbnail

Janssen seeks EU approval for first CAR-T therapy cilta-cel

Pharma Times

Cilta-cel is an investigational CAR-T cell therapy for the treatment of relapsed/refractory multiple myeloma

149
149
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh

Pharma Mirror

Terrassa (Barcelona). Azbil Telstar announces the appointment of Rashedi Hassan as a Sales & Marketing Manager of the subsidiary of the company in Dhaka, Bangladesh. From 14th February 2021, Rashedi Hassan focuses his responsibility on developing extensive marketing and sales plan to strengthen the Telstar brand position in the local pharmaceutical market and to promote the presence and distribution of Telstar branded Life Sciences service & product solutions in the region, particularly

article thumbnail

Which pharmaceutical companies have the most suspension dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most suspension dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suspension dosed drugs…. The post Which pharmaceutical companies have the most suspension dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

More Trending

article thumbnail

UK ‘planning to widen AstraZeneca COVID jab restrictions’

pharmaphorum

Reports are emerging that the UK may join other countries in imposing restrictions on the use of AstraZeneca’s COVID-19 vaccine in younger people, after a fresh look at the risks and benefits of the shot. . The Joint Committee on Vaccination and Immunisation (JCVI) said last month that it is preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the AZ/Oxford University adenovirus-based vaccine where available.

Vaccines 130
article thumbnail

Explore vital drug delivery innovations at online event

Outsourcing Pharma

On May 5, a panel of experienced industry experts will discuss recent developments during Innovations in Drug Delivery, a free one-hour industry webinar.

115
115
article thumbnail

AZ' Tagrisso first to win MHRA approval under Project Orbis

Pharma Times

Decision brings the innovative treatment to early-stage lung cancer patients, helping to address unmet need in this setting

131
131
article thumbnail

Virtual Reality – FDA and AdComms

Eye on FDA

Vaccination has been robust. Cities are opening up. Plans are underway for back-to-school. Travel is robust. Offices are cautiously re-opening. There are multiple hallmarks that, whatever the consequences, we are going back to normal. The age of COVID-19 will likely continue, but with the emergence of a significant proportion of the population with vaccines pumped into them, we headed back on almost every level.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

New patent expiration for Osi Pharms drug TARCEVA

Drug Patent Watch

Annual Drug Patent Expirations for TARCEVA Tarceva is a drug marketed by Osi Pharms and is included in one NDA. It is available from one supplier. There are two patents…. The post New patent expiration for Osi Pharms drug TARCEVA appeared first on DrugPatentWatch - Make Better Decisions.

98
article thumbnail

W.H.O. Approves China’s Sinopharm Vaccine for Emergency Use

NY Times

Sinopharm is the first Chinese shot to be classified as safe and effective by the World Health Organization, allowing the vaccine to be more widely distributed to poor and middle-income nations.

article thumbnail

Tackling diabetes & ALS with cell therapy

pharmaphorum

Israeli company Kadimastem is developing regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as Amyotrophic lateral sclerosis (ALS) and diabetes. Catherine Longworth spoke with Kadimastem’s head of diabetes research, Kfir Molakandov to find out more. In the 1990s, when the first transplant of islets took place, it was hailed as the cure for diabetes.

Diabetes 126
article thumbnail

Artificial intelligence can elevate pharma manufacturing

Outsourcing Pharma

According to a leader from industrial AI specialist AspenTech, AI can help avoid costly maintenance interruptions by predicting when upkeep is needed.

112
112
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Janssen inks inflammatory disease collaboration with Mestag Therapeutics

Pharma Times

Collaboration will utilise Mestag’s specialist fibroblast subpopulation biology platform to identify novel therapeutic targets

123
123
article thumbnail

5 Ways Pharma Can Create Quality Experiences for HCPs

Pharma Marketing Network

Laura Dix, Managing Director, Life Sciences, UK breaks down ‘5 ingredients’ that are sure to make a positive impact in the interaction between pharma marketers and healthcare professionals (HCPs). COVID-19 drastically changed the playing field of HCP communication and engagement. Dix reminds us that the time has never been so important to truly differentiate when creating high-quality experiences for HCPs – experiences that HCPs deserve and will crave more of in the future when treating p

article thumbnail

Which pharmaceutical companies have the most SPCs in Estonia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Estonia. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Estonia? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Taking ‘Extraordinary Measures,’ Biden Backs Suspending Patents on Vaccines

NY Times

The Biden administration, siding with some world leaders over the U.S. pharmaceutical industry, came out in favor of waiving intellectual property protections for coronavirus vaccines.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Why relationships are key in rare disease patient engagement

pharmaphorum

Real-world data is a vital part of rare disease drug development, but to get a true picture of patients’ unmet needs pharma should take a broader view of their lived experiences, says Xperiome’s Jeremy Edwards. It is difficult to get data on rare diseases and the people who live with them by their very nature. But these patients face unique challenges in their everyday lives that pharma needs to account for when developing treatments, and understanding these challenges requires strong real-world

article thumbnail

Reify, SubjectWell partner to elevate trial recruitment

Outsourcing Pharma

The two tech-focused firms are joining forces to work on technology solutions aimed at improving patient recruitment and enrollment for various studies.

105
105
article thumbnail

EMA, MHRA to review Vertex' Kaftrio for children with CF

Pharma Times

If approved, up to 2,000 children with CF would be eligible for treatment with the drug

146
146
article thumbnail

Once in a Lifetime: Customer Experience at Momentous Moments

Pharma Marketing Network

Some moments in life are profoundly important. Perhaps you’ve saved carefully for years to take your family on a special vacation. Or perhaps you’ve just been given a life-changing diagnosis that’s left you in a state of shock. Whether positive or negative, in a moment that important, you’re living in an altered state. Things might seem overwhelming, with the world moving too fast for you to understand what’s going on; or you may freeze, and it may feel like reality has slowed to a crawl.

87
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

New patent for Teva Pharm drug ARMONAIR RESPICLICK

Drug Patent Watch

Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are nineteen…. The post New patent for Teva Pharm drug ARMONAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.

91
article thumbnail

Pfizer Will Seek Approval to Give Covid Vaccine to Children

NY Times

The company said it also plans to apply this month for full F.D.A. approval — not just emergency authorization — for the vaccine’s use in adults.

article thumbnail

UK says Pfizer, AZ COVID-19 vaccines work against Indian variant

pharmaphorum

People who have received two doses of the AstraZeneca or Pfizer/BioNTech COVID-19 vaccines have good protection against the Indian variant of SARS-CoV-2 , according to new UK data. The Pfizer/BioNTech shot provided 88% protection against the B.1.617.2 variant first identified in India and currently gaining ground across the UK and other countries around the world, according to the Public Health England (PHE) study.

Vaccines 124
article thumbnail

CPhI survey: pharma leaders optimistic about the future

Outsourcing Pharma

According to a recent survey of executives conducted by CPhI, COVID-19âs impact is driving manufacturing and CDMOs are fueling industry growth.

108
108
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Researchers find CD38-targeting drugs may show promise against prostate cancer

Pharma Times

Researchers are initiating clinical trials to evaluate whether targeting the CD38 pathway can provide benefit for people with prostate cancer

115
115
article thumbnail

DarshanTalks: How To Build a Trusted Workforce – May 14, 2021

Pharma Marketing Network

[link]. The post DarshanTalks: How To Build a Trusted Workforce</br> – May 14, 2021 appeared first on Pharma Marketing Network.

96
article thumbnail

Which pharmaceutical companies have the most SPCs in Spain?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Spain? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Pfizer Seeks Full FDA Approval for Its Covid-19 Vaccine

NY Times

The vaccine has been used under an emergency authorization since December. A decision by the Food and Drug Administration could take months.

article thumbnail

Now what? The future of clinical trials after the pandemic

pharmaphorum

Sheila Rocchio highlights four key areas life sciences must improve on as an industry to drive real change in how clinical trials are conducted. This is definitely a time for the life sciences industry to be proud of our accomplishments. The way in which the industry came together to support the development of the COVID-19 vaccines has shown that it is equally important to determine how to apply the lessons of the last year to the future.

Vaccines 119